Mead Johnson Nutrition — 2014 Conference
48 slides from Mead Johnson Nutrition's conference presentation, Feb 20, 2014
Slide 1: 2014 Conference
2014 Conference February 20, 2013 Kasper Jakobsen President and CEO
Slide 2: Forward-Looking Statements
1 Forward-Looking Statements Certain statements in this presentation are forward-looking as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the fact they use words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “
Slide 3: MJN Celebrates 5 Year IPO Anniversary
“Mead Johnson Ends IPO Dry Spell” 2 IPO Index Performance MJN celebrates 5 year IPO anniversary S&P Food S&P 500 MJN
Slide 4: MJN Ambition
3 MJN Ambition Our Ambition is to deliver superior revenue and earnings growth within the top quartile of peer group; We plan to achieve this through Increased market share of core categories Revenue growth at or above category growth rate Grow long-term earnings at or above the rate of revenue grow
Slide 5: External Drivers of Growth
4 Economic Growth and Job Creation Increasing Spend on Premium Nutrition Increasing Number of Women in Workforce Middle Class and Dual-Income Families Emerge Trends Driving Growth Kilograms per Birth Births/1,000 Population 2012 Birth Rate 2012 IF-GUM* Volume Consumption External Drivers of Growth S
Slide 6: Strategy for Growth
5 Economic Growth and Job Creation Increasing Spend on Premium Nutrition Increasing Number of Women in Workforce Middle Class and Dual-Income Families Emerge Trends Driving Category Unwavering commitment to quality Investment in innovation and demand creation behind our core business Areas of focus
Slide 7: Continuous Revenue Growth at or above Category Growth Rate
6 6 +14% ~ +7% +9% +9% Middle East/Africa(1) Latin America Europe North America Asia(2) Category Growth 6-7% CAGR MJN Sales Growth3 2010 2011 2012 2013 2014E +7% Category Source: ERC forecasts as of June 2013 (1) Includes Middle East, North Africa and RSA (2) Asia includes Australia & New Zealand (3
Slide 8: Revenue Drives EPS Growth Over Time
7 MJN Growth1 Sales Non-GAAP EPS 2010 2011 2012 2013 2014E Estimate Long term earnings growth at or above the rate of revenue growth +15% 4%-7% +9% +10% +10% +14% ~ +7% +9% +9% +7% 2014 Guidance anticipates unusual coincidence of headwinds: Weakness in Emerging Market currencies, especially Venezuel
Slide 9: Our Geographic Portfolio
8 Our Geographic Portfolio Based on 2013 net sales, order is alphabetical within above grouping Asia and Latin America comprise 72% of Global Business MJN Operating Regions MJN Top Markets Mega Markets Mexico Canada Large Markets Malaysia Philippines Thailand Argentina Mid-size Markets Brazil Indone
Slide 10: Building on Strong Foundations
Total Category #1 9 Greater China South Asia China / HK #1 Premium Segment #3 Malaysia #1 #2 Thailand #1 #4 Vietnam #2 #3 Philippines #2 South America Argentina #1 #2 Brazil* #4 #4 Mexico Total Category Premium Segment Mexico #2 #1 #2 Colombia #1 #2 Ecuador #1 Peru #1 #1 Central America #1 Panamá Ni
Slide 11: Case Studies Exemplifying Growth Strategy
10 Leveraging Science Core into Growing Up Milks Underpinning Strong Category Growth Drivers Seed Market Expansion Expanding Reach In China Case Studies exemplifying Growth Strategy
Slide 12: Case Study #1: Innovation, Science, Toddlers
11 Science-based Innovation Case Study # 1: Innovation, Science, Toddlers
Slide 13: Clinically Proven Superior Performance
79 33 24 18 Infants acquiring tolerance (%) Significantly more infants built oral tolerance to cow milk protein after 1 year of Nutramigen LGG (P<O.O5)* Tolerance to Cow Milk Protein at 12 months Conclusion: “The current study shows that EHCF [extensively hydrolyzed casein formula] with LGG induces
Slide 14: Next Generation Growing Up Milks
Toddlers’ diets are challenging: Many get only 1/3 of the recommended DHA each day Often consume foods that cause glucose to rise rapidly and then fall Our new toddler products: DHA at expert recommended levels Clinically proven steady glucose supply 13 Formulations Next Generation Growing Up Milks
Slide 15: Leveraging Science Beyond The First Year
14 0 – 12 Months 9 – 36 Months 0 – 3 Months Leveraging Science Beyond The First Year
Slide 16: Toddler Category Growing In The US
15 U.S. Toddler Category Under Developed vs. Europe(1) MJN Children Sales in the U.S. are Significantly Under Developed vs. Infant(2) Enfagrow: MJN Largest Global Brand 25%+ YTD U.S. Europe Enfagrow Volume Sales Trend Source: Nielsen (2012) Source: MJN 2012 10K Source: Nielsen Foundations of the Glo
Slide 17: Knowledge Gap Presents Opportunity
Source: Company Research 16 1 in 10 Moms Are Users 3 months Average Length of Use National TV Advertising 1 in 3 Moms Are Aware of Category AWARENESS TRIAL REPEAT Knowledge Gap Presents Opportunity
Slide 18: Case Study #2: China
17 City and Channel Extension Case Study # 2: China
Slide 19: The China Opportunity
The China Opportunity Large market $8 billion Infant & Growing Up Mile category with 16+ million births annually Competitive and fragmented, but consolidating >100 companies Vast and operationally complex Significant opportunity in top-tier and lower-tier cities Developing Channels Significant oppor
Slide 20: Internet Channel Fueling Incremental Growth
20 Internet channel fueling incremental growth Internet channel predominantly Consumer-to-Consumer 20 C2C Other B2C B2C TMall Equivalent in US C2C: Ebay B2C: Amazon Category Sales MJN Launches - 2013 Opportunity for Internet Expansion Source: Smart Path in YTD Jul 2013
Slide 21: The Path Forward
Developing New Segments Building On Relationships Expanding Into New Channels Continued Steady City Expansion Specialty Solutions Baby Stores eCommerce 21 The Path Forward Innovation and Execution are key to sustaining growth Source: City segmentation based on China government statistical yearbook,
Slide 22: Case Study #3: Brazil
22 Seed Market Expansion Case Study # 3:Brazil
Slide 23: Our History In Brazil
1957 Sustagen - leads Nutritional Complement category Enfamil launched Sustagen Plant Acquisition 2011 Medical Sales Force execution focus City Expansion 2012 Enfagrow launched Sustagen RTD Launch Enfamil + 4pt share(1) 2013 23 Our History In Brazil (1) Source: CCR, IMS YTD August 2013 vs. year ago
Slide 24: Attractive Developing Market
200+ million population with 3 million births annually – and growing Large economy with growing middle class and rising per capita income Unemployment rate of 4.6% low despite current challenges Female participation in workforce still below 50% 24 Graph Source: Goldman Sachs, US$ in Purchasing Power
Slide 25: A Large and Growing Market
25 2013 2018 USD MM 2013 (P) Sales $4.4 B Sales $6.8 B Category will grow 50% in five years A Large and Growing Market. Nielsen + IMS and Company Research
Slide 26: Building Capabilities For The Future
Invested competitively in demand generation Developing ‘seed’ markets Gained Market Share over past 5 years Expanding Manufacturing Capacity - Singapore Launched ~ 150 new products since 2009 Opened new Pediatric Nutrition Institutes in the U.S., Mexico and China Sales Force employees increased 7% s
Slide 27: MJN Ambition
27 MJN Ambition Our Ambition is to deliver superior revenue and earnings growth within the top quartile of peer group; We plan to achieve this through Increased market share of core categories Revenue growth at or above category growth rate Grow long-term earnings at or above the rate of revenue gro
Slide 28: Financial Highlights
28 Financial Highlights Pete Leemputte EVP and CFO
Slide 29: Strong Financial Performance
29 +8% 2008-2013 CAGR +12% Sales, $ B Non-GAAPEPS Constant Dollar Sales Growth ~ +7% +9% +7% +14% +9% +15% +10% +10% +4%-7% +9% Strong sales growth has been leveraged into even higher growth in EPS Strong Financial Performance +3% +17%
Slide 30: Volume Growth Strong Across Asia and Latin America
31 Latin America Asia 2009 2010 2011 2012 2013 Volume - Organic Price Volume for NA/Europe is presented on a reported basis. Core volumes for NA/Europe, excluding non-core businesses exited in late 2012, are flat YTD 2013. Volume growth has been strong across Asia and Latin America 8% 7% 2008-2013 C
Slide 31: Constant $ Sales Growth by Segment
32 North America & Europe Asia 2009 2010 2011 2012 2013 In 2014 we expect to see continued strong growth in Asia and Latin America, and a return to growth in North America/Europe Latin America 2014E Growth Similar to 2013 Double Digit Growth Low Single Digit Growth Constant $ Sales Growth by Segment
Slide 32: FX Impact on Reported Sales Growth
33 If current exchange rates are maintained, sales growth would be reduced by about 2.5% and EPS by $0.08 per share in 2014 versus 2013 FX Impact on Reported Sales Growth Asia North America/ Europe Latin America The dollar has strengthened noticeably against many currencies, reducing reported sales
Slide 33: Managing FX Sales Exposure
34 2013 Sales $4.2 Bil Greatest FX exposure is in emerging markets outside China and HK Represents less than half our sales base Higher pricing offsets the impact of a strengthening dollar Impact of Pricing and FX on Sales Growth 2012 2013 Region Price FX Price FX Latin America +7% -6% +11% -8% Sout
Slide 34: Venezuela: Significant Uncertainty
Venezuela: Significant Uncertainty 35 The wider range in our January EPS guidance reflects greater uncertainty in Venezuela Venezuela accounted for about 2% of sales in 2013 Strong volume gains in 2013 due in part to product movement from VZ into other markets Government introduced new dual exchange
Slide 35: Gross Margin: Inflation vs. Productivity
Gross Margin: Inflation vs. Productivity COGS Productivity Target 3% of COGS productivity each year 2013 COGS Dairy Spot Prices Savings as % of COGS $/kg Note: WMP = Whole Milk Powder; NFDM = Non-Fat Dry Milk 36 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 $6.00 Jan 09 Apr 09 Jul 09 Oct 09 Jan 10 Apr 10 Jul
Slide 36: Margin Trends
37 Gross Margin EBIT Operating Expenses In 2014, we are managing the business to offset the impact of higher dairy costs and the Singapore plant start-up through greater leverage of operating expenses Margin Trends Measured as a % of Sales Even with dairy headwind and Singapore start-up costs, we ar
Slide 37: Strong and Stable Free Cash Flow
38 (1) Working Capital defined as receivables, inventory and accounts payable. Strong and Stable Free Cash Flow We retain significant financial flexibility given strong cash generation Free Cash Flow $ in Millions 2010 2011 2012 2013 Net Earnings $458 $519 $612 $655 Depreciation and Amortization $65
Slide 38: Returning Cash to Shareholders
Quarterly Dividend Per Share Potential Acquisitions Within Core 39 Returning Cash to Shareholders $ in Millions 2010 2011 2012 2013 Free Cash Flow $342 $523 $569 $567 Dividends ($180) ($206) ($237) ($268) Share Repurchases ($2) ($88) ($155) ($106) Total Return to Shareholders ($182) ($294) ($392) ($
Slide 39: Year-End Cash Balance and Repatriation
40 $596 $1,051 $1,042 $840 U.S. Outside U.S. Cash Returned to Shareholders $182 M $294 M $392 M $374 M Net Pretax Interest Expense $49 M $52 M $65 M $51 M Year-End Cash Balance It is necessary to repatriate earnings from abroad to meet cash needs in the U.S. $400 MM return of basis from abroad
Slide 40: Strong Progress to Reduce Tax Rate
41 Top Markets 2014 Rate U.S. 37% Mexico 30% Philippines 30% Canada 27% China 25% Malaysia 25% Thailand 20% Hong Kong 17% Netherlands Single Digit Singapore Single Digit Drivers of Future ETR Lower ETR Higher ETR Benefit of Manufacturing Profit from New Singapore Spray Dryer Once Fully Operational P
Slide 41: Capital Returns to Normal Level in 2014
42 Spending Focus Range Growth 40 - 50% Productivity 10 - 20% Quality 10 - 20% Maintenance 20 - 30% SAP and Systems Investment Baseline Capital Singapore Spray Dryer & Technology Center Capital Returns to Normal Level in 2014
Slide 42: Full Year Guidance
43 43 Guidance provided in Press Release dated January 31, 2014. GAAP EPS guidance is $3.44 to $3.56, which includes $0.06 per diluted share of specified items. The company is planning to adopt mark-to-market pension accounting during 1Q 2014. The above guidance does not reflect this change in accou
Slide 43: Our Commitment To Our Shareholders
44 Our Commitment To Our Shareholders MJN Ambition Our Ambition is to deliver superior revenue and earnings growth within the top quartile of peer group; We plan to achieve this through Increased market share of core categories Revenue growth at or above category growth rate Grow long-term earnings
Slide 44: Thank You
Thank You Meadjohnson Nutrition
Slide 45: Reconciliation of GAAP to non-GAAP
46 Reconciliation of GAAP to non-GAAP $ in millions FY FY FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Net Sales GAAP $2,826.5 $3,141.6 $3,677.0 $986.6 $1,012.3 $921.3 $981.1 $3,901.3 $1,037.9 $1,055.3 $1,046.8 $1,060.7 $4,200.7 Adjustments: (None) Non-GAAP $2,826.5 $3,141.6 $3,677.0 $986.6 $1,012.3 $921.3 $981
Slide 46: Reconciliation of GAAP to non-GAAP
47 Reconciliation of GAAP to non-GAAP In millions, except per share data FY FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Earnings Before Income Taxes GAAP $587.0 $634.3 $209.5 $191.5 $188.6 $132.3 $721.9 $234.3 $230.7 $166.3 $173.7 $805.0 $234.9 $219.2 $226.4 $193.5 $874.0 Adjustments: IT and oth
Slide 47: Reconciliation of GAAP to non-GAAP
48 Reconciliation of GAAP to non-GAAP In millions, except per share data FY FY FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Net Earnings GAAP $410.6 $458.2 $519.0 $169.8 $171.1 $139.2 $132.3 $612.4 $174.5 $163.6 $160.0 $156.8 $654.9 Adjustments: IT and other separation costs 19.2 57.1 74.7 1.7 5.4 4.9 7.9 19.9
Slide 48: Supplemental Financial Information
49 Supplemental Financial Information 2009 2010 Net Sales Growth 1 FY FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Total Company Volume -3% 5% 11% 17% 7% 11% 11% 5% 3% -5% 2% 1% -1% 2% 12% 6% 5% Price / Mix 5% 4% 4% 1% 4% 3% 3% 4% 8% 6% 5% 6% 6% 2% 4% 5% 4% Constant Dollar Sales 2% 9% 15% 18% 11%